We are live on ! Find out more
GMED icon

Globus Medical

449 hedge funds and large institutions have $7.74B invested in Globus Medical in 2024 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 147 increasing their positions, 176 reducing their positions, and 52 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $3.38M

2% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 52

0% more capital invested

Capital invested by funds: $7.72B → $7.74B (+$15.6M)

0% less funds holding

Funds holding: 450449 (-1)

4.38% less ownership

Funds ownership: 100.09%95.72% (-4.4%)

16% less repeat investments, than reductions

Existing positions increased: 147 | Existing positions reduced: 176

18% less funds holding in top 10

Funds holding in top 10: 2218 (-4)

Holders
449
Holders Change
-1
Holders Change %
-0.22%
% of All Funds
6.45%
Holding in Top 10
18
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-18.18%
% of All Funds
0.26%
New
53
Increased
147
Reduced
176
Closed
52
Calls
$13.5M
Puts
$3.38M
Net Calls
+$10.2M
Net Calls Change
-$2.8M
Name Holding Trade Value Shares
Change
Change in
Stake
MNBTD
326
Moody National Bank Trust Division
Texas
$252K -$58.6K -830 -19%
PAM
327
Panagora Asset Management
Massachusetts
$243K -$7.55K -107 -3%
CIBC Asset Management
328
CIBC Asset Management
Ontario, Canada
$237K +$8.4K +119 +4%
IWC
329
Integrated Wealth Concepts
Massachusetts
$236K +$6.28K +89 +3%
CI Investments Inc
330
CI Investments Inc
Ontario, Canada
$236K -$10.4K -147 -4%
ATC
331
Argent Trust Co
Tennessee
$235K -$9.46K -134 -4%
BWG
332
Berry Wealth Group
Texas
$232K +$229K +3,245 New
FTDI
333
First Trust Direct Indexing
Massachusetts
$221K -$4.73K -67 -2%
Baird Financial Group
334
Baird Financial Group
Wisconsin
$218K -$14.3K -203 -6%
OGF
335
Orin Green Financial
California
$215K +$212K +3,001 New
CAM
336
Claret Asset Management
Quebec, Canada
$213K +$1.13K +16 +0.5%
RJT
337
Raymond James Trust
Florida
$205K +$202K +2,867 New
PA
338
Profund Advisors
Maryland
$205K +$202K +2,866 New
ECM
339
Evergreen Capital Management
Washington
$202K +$199K +2,823 New
IWM
340
IHT Wealth Management
Illinois
$201K +$198K +2,806 New
Lazard Asset Management
341
Lazard Asset Management
New York
$188K +$1.2K +17 +0.6%
TRCT
342
Tower Research Capital (TRC)
New York
$165K -$256K -3,632 -61%
Simplex Trading
343
Simplex Trading
Illinois
$163K +$162K +2,288 New
PCM
344
Palouse Capital Management
Washington
$133K -$86.5K -1,226 -40%
VI
345
Vestcor Inc
New Brunswick, Canada
$122K -$569K -8,059 -82%
CIBC Private Wealth Group
346
CIBC Private Wealth Group
Georgia
$119K +$15.9K +225 +16%
AF
347
Allworth Financial
California
$114K +$565 +8 +0.5%
MG
348
Mather Group
Illinois
$83.4K -$11.6K -165 -12%
Nisa Investment Advisors
349
Nisa Investment Advisors
Missouri
$83.3K
HIA
350
Harbor Investment Advisory
Maryland
$80.5K

GMED Hedge Fund Activity: Q3 2024 in Review

449 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2024, worth a combined $7.74B — up 0.2% from $7.72B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new GMED positions and 52 closed out — a net gain of 1 holder — while 147 added to existing stakes and 176 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $56.9M. The largest seller was Vestal Point Capital, exiting entirely with an estimated $61.6M sold.

  • 449 institutional investors held Globus Medical (GMED) as of Q3 2024, down from 450 in Q2 2024.
  • Funds reported $7.74B of Globus Medical stock for Q3 2024, up 0.2% quarter-over-quarter.
  • 53 funds opened new Globus Medical positions in Q3 2024 and 52 closed out, a net change of +1 holder.
  • The largest Globus Medical buyer in Q3 2024 was Citadel Advisors, an estimated $56.9M added.
  • The largest Globus Medical seller in Q3 2024 was Vestal Point Capital, an estimated $61.6M sold.

Based on aggregated 13F filings for Q3 2024.